secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001193125-23-163516
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Verrica shareholders re-elect three directors; ratify KPMG as auditor for FY2023
--------------------------------------------------------------------------------

- All three director nominees elected: Ballaron (16,697,734 for), Manning (16,965,570), Eichenfield (16,400,406); 17,862,320 broker non-votes.
- Ratification of KPMG LLP as independent auditor for FY2023: 34,915,802 for, 1,088 against, 13,730 abstain.
- 83.46% of 41,852,053 outstanding shares were present or represented at the June 8, 2023 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312523163516/0001193125-23-163516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312523163516/d468217d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-163516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer